One of the main risks facing any new technology is its acceptance by the end-user.
Led by Professor Rosanna Peeling at the London School of Hygiene and Tropical Medicine, the aim of Flagship 1 is to overcome this risk from the outset, by gaining an understanding of end‐user needs for an early-warning sensing system and the potential impact of such a system on existing clinical and surveillance practices.
We are engaging with a wide range of potential users of our technologies, including clinical leads, hospital managers, patient representatives and healthcare commissioners in the UK and in select countries in Asia and Africa.
We aim to identify how and where new sensing systems can bring maximum benefit and to evaluate the impact of our technologies on influenza, bacterial infections and HIV. This will help us design the system required to meet the needs of the end-user.
We are evaluating current early warning systems and assessing the characteristics of our sensors such as sensitivity, specificity, stability and cost in order to deliver high-performance systems, adapted for our specific disease targets.